Copies of extracts of Standalone Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2025, published in newspapers today, i.e., January 24, 2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Zenotech Laboratories has submitted copies of newspaper extracts containing its standalone unaudited financial results for the quarter and nine months ended December 31, 2025. The results were published in Business Standard (English) and Telugu Prabha (Telugu) editions on January 24, 2026. This is a routine regulatory compliance filing made under Regulation 47 of the SEBI Listing Regulations, 2015. The letter is signed by Abdul Gafoor Mohammad, Company Secretary and Compliance Officer, and lists the company's ISIN (INE486C01031) and BSE scrip code (532039). No specific financial figures from the company's results are visible in the readable portion of the document.
This is a standard compliance disclosure with no direct impact on the stock price. Investors should look for the actual Q3 FY26 results — revenue, profit/loss, and margin trends — in the published results for any meaningful takeaways.